Sun-damaged skin: People with sun-damaged skin have a higher risk for developing AKs.
Imiquimod (ih-mih-kwih-mod) is a prescription medicine that you use at home. It comes in a cream that you apply to your skin. Your dermatologist may prescribe imiquimod to treat:
Sometimes, a dermatologist will prescribe imiquimod to treat another skin condition.
For your dermatologist to prescribe imiquimod, you must:
Imiquimod treatment: Patient’s skin reacts while using imiquimod to treat early basal cell cancer (left). The same patient, 8 months later, cleared of the skin cancer (right).
Many patients see actinic keratoses (AKs) and the earliest form of basal cell cancer clear. This medicine also destroys genital warts.
Some patients, however, continue to get new AKs, skin cancers, or genital warts. Imiquimod can destroy a tumor or wart — but not its cause.
What causes AKs and skin cancers: AKs and skin cancers develop in people who use tanning beds, sunlamps, or do not protect their skin from the sun. Tanning beds, sunlamps, and the sun damage our skin. When the damage is severe, new AKs and skin cancers can form. Protecting your skin from the sun and not using tanning beds or sunlamps helps to reduce the chance of new getting AKs and skin cancers.
You apply the cream to the AKs, skin cancer, or warts. Most patients apply imiquimod before bedtime. You must leave imiquimod on your skin for several hours and then wash it off.
Be sure to follow the directions carefully. Using more than directed can cause unwanted skin reactions. If you use the medicine less often than prescribed, it may not work.
This varies from patient to patient. Your dermatologist will tell you how long you will need to use the cream and how often to apply it. The following table shows the typical treatment plan for each of the skin diseases that the U.S. Food and Drug Administration (FDA) approved imiquimod to treat.
How to use imiquimod
Skin disease | How often apply | How long keep it on your skin | How long use |
AKs | 2 days a week | 8 hours | 16 weeks |
Early basal cell carcinoma | 5 days a week | 8 hours | 6 weeks, continuing to use even if tumor disappears |
Genital warts | 3 days a week | 6 to 10 hours | Maximum of 16 weeks |
Imiquimod stimulates the patient’s immune system. This helps the patient’s body to destroy the genital warts, AKs, or cancer cells.
When using imiquimod to treat AKs or skin cancer, your skin should react. You may have redness, swelling, burning, itching, and tenderness. As the skin starts to heal, you will see scabs and flaking. These reactions indicate that the medicine is working. When a patient does not have a reaction, imiquimod tends to be ineffective.
When using this medicine, you should:
It is normal to have a skin reaction. This tells you that the medicine is working. You may experience redness, swelling, and itching. If the intensity becomes too much, you should contact your dermatologist. Your dermatologist can adjust the dose or frequency to make you more comfortable.
If you experience any of the following side effects, you should contact your dermatologist:
If you are treating AKs, you may see more AKs on your skin. This happens frequently and should not worry you.
Images used with permission of Journal of the American Academy of Dermatology J Am Acad Dermatol. 2002; 47:S240-8.
Imiquimod treats many patients safely and effectively, but it is not right for everyone. If your dermatologist mentions imiquimod as a possible treatment, be sure to tell your dermatologist if you have:
You also should tell your dermatologist if you take:
If you have any concerns about using imiquimod, you should tell your dermatologist. Dermatologists have been prescribing this medicine for years. In fact, dermatologists led many of the clinical trials for imiquimod. This makes dermatologists very familiar with the medicine and knowledgeable about whom it can help.
Before talking about concerns, it may be helpful to know the advantages and disadvantages of using this medicine, which are shown below.
Advantages | Disadvantages |
|
|
Dermatologists continue to lead research studies that look at how imiquimod can help improve the lives of their patients.
© 2019 American Academy of Dermatology. All rights reserved. Reproduction or republication strictly prohibited without prior written permission. Use of these materials is subject to the legal notice and terms of use located at https://www.aad.org/about/legal